Pankit Vachhani (@pankitvachhani) 's Twitter Profile
Pankit Vachhani

@pankitvachhani

Associate Prof of Medicine at UAB Comprehensive Cancer Center

ID: 105676426

calendar_today17-01-2010 03:35:18

60 Tweet

261 Followers

316 Following

Sankalp Arora, MD (@sankalparoramd) 's Twitter Profile Photo

Hot off the press: Our letter describing survival outcomes of patients with acute myeloid leukemia UAB O'Neal Comprehensive Cancer Center following relapse/refractoriness to HMA/Ven. tandfonline.com/doi/full/10.10… Enjoyed partnering with my UAB Tinsley Harrison IM Residency co-resident Carl on this one! Pankit Vachhani #Onclive

UAB Medicine (@uabmedicine) 's Twitter Profile Photo

Sylacauga, Ala. resident James Wilkins is fighting a rare and aggressive cancer called “double-hit” lymphoma, and he’s showing signs of winning, thanks in part to an innovative treatment called CAR T-cell therapy that’s available at the UAB O'Neal Comprehensive Cancer Center.  fal.cn/3s1iv

Noha Sharafeldin, MD, MSc, PhD (@nohasharafeldin) 's Twitter Profile Photo

Grateful and honoured beyond words to be recognized yet again by an organization with the dedication vision and undeniable impact such as The Leukemia & Lymphoma Society I owe a lot to all the support and even more excited about the future!!

Prithviraj Bose (@bose_prithviraj) 's Twitter Profile Photo

Important update on the navtemadlin single agent phase 2 trial in R/R MF eloquently presented by Pankit Vachhani at #EHA23: impressive survival data and look forward to the readout of #BOREAS! Kartos Therapeutics #EHA23 #sergeverstovsek MD Anderson Cancer Center

Important update on the navtemadlin single agent phase 2 trial in R/R MF eloquently presented by <a href="/pankitvachhani/">Pankit Vachhani</a> at #EHA23: impressive survival data and look forward to the readout of #BOREAS! <a href="/KartosThera/">Kartos Therapeutics</a> #EHA23 #sergeverstovsek <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Pankit Vachhani (@pankitvachhani) 's Twitter Profile Photo

I am honored to be a judge for the 2023 #MPNHeroes Recognition Program, recognizing people going above and beyond in their efforts to support patients with an #MPN. Submit your nominations by 9/14! tinyurl.com/5n6f9v9a. #Sponsored Incyte CURE Today

Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

Happy to share our review on #MPNsm A true clinical & pathological approach written w/ my friends Prithviraj Bose Pankit Vachhani See if you can guess the Dx from image before looking at the paper 😉 Free full text: authors.elsevier.com/c/1iZqS7fNb0Dz…

Happy to share our review on #MPNsm A true clinical &amp; pathological approach written w/ my friends <a href="/bose_prithviraj/">Prithviraj Bose</a> <a href="/pankitvachhani/">Pankit Vachhani</a> 
See if you can guess the Dx from image before looking at the paper 😉
Free full text:
authors.elsevier.com/c/1iZqS7fNb0Dz…
Prithviraj Bose (@bose_prithviraj) 's Twitter Profile Photo

Check out our comprehensive, state of the art review on interferons in #MPNSM #referencesontap): ncbi.nlm.nih.gov/pubmed/38380373

The Tisch Cancer Institute (@tischcancer) 's Twitter Profile Photo

A novel application of XPO1 inhibition for the treatment of myelofibro... sciencedirect.com/science/articl… From Dr. John Mascarenhas; HemOnc fellows Icahn School of Medicine at Mount Sinai: Drs. Megan Metzger, Zachary Avigan, Julian Waksal; and Pankit Vachhani

Pankit Vachhani (@pankitvachhani) 's Twitter Profile Photo

Please join us 3-6pm PT at the Friday Satellite Symposium on myelofibrosis. Jeanne M Palmer Marina Kremyanskaya, MD, PhD You know it will be the best one at ASH 🤗😉. Make sure to register👇! Safe travels to all. ☀️✈️🙏 #mpnsm #ASH2024 Mayo Clinic The Tisch Cancer Institute UAB O'Neal Comprehensive Cancer Center

Prithviraj Bose (@bose_prithviraj) 's Twitter Profile Photo

Happy to share our latest review on the latest JAKi (granted not so new any more) to be approved for MF! Great job Ruchi Desai and thanks ⁦Pankit Vachhani⁩ for the creative title! #MPNSM ⁦ tandfonline.com/doi/full/10.10…